Results 21 to 30 of about 26,226 (199)

Fondaparinux-associated Thrombocytopenia

open access: yesPakistan Journal of Medical Sciences, 2021
Heparin-induced thrombocytopenia (HIT) is an immune-mediated condition causing thrombocytopenia and paradoxical thrombosis after exposure to heparin or low-molecular-weight heparin. It has been rarely reported by Fondaparinux, an artificial pentasaccharide similar to heparin. This manuscript presents a case of HIT associated with fondaparinux use. doi:
Malik, Jahanzeb   +2 more
openaire   +3 more sources

Enoxaparin vs Fondaparinux Dalam Penurunan CK-MB [PDF]

open access: yes, 2020
Ischemic Heart Disease (Non ST Elevated Myocardial Infarction-NSTEMI) is the leading cause of death in Indonesia after Stroke. Enoxaparin and Fondaparinux are the drugs of choice for this condition.
sukmawan, yedy purwandi   +5 more
core   +1 more source

Anti Xa Aktivität unter Fondaparinux bei therapeutisch und prophylaktisch antikoagulierten kardiovaskulären Patienten [PDF]

open access: yes, 2022
In dieser Studie wurde der Fondaparinux-Serumspiegel an den ersten 5 Tagen je 2 Stunden nach subkutaner Applikation bestimmt. Unter therapeutischer Dosierung von Fondaparinux lag die Anti Xa Aktivität an Tag eins relevant außerhalb des Zielbereichs ...
Geisler, Andreas Christian
core   +1 more source

Comparison between unfractionated heparin (UFH) and fondaparinux on platelets and D-dimer level in COVID-19 patients with hypercoagulation [PDF]

open access: yes, 2022
Introduction: This study aimed to compare the clinical effects between UFH and fondaparinuxin COVID-19 patients with hypercoagulation. Material and methods: This was a prospective cohort study.
Hanestya Oky Hermawan, -   +14 more
core   +1 more source

Use of Fondaparinux Following Elective Lumbar Spine Surgery Is Associated With a Reduction in Symptomatic Venous Thromboembolism

open access: yesGlobal Spine Journal, 2020
Study Design: Retrospective cohort study. Objective: To assess the impact of fondaparinux on venous thromboembolism (VTE) following elective lumbar spine surgery in high-risk patients. Methods: Matched patient cohorts who did or did not receive inpatient
Mitchell S. Fourman MD, MPhil   +8 more
doaj   +1 more source

The clinical course of symptomatic deep vein thrombosis after 3 months of anticoagulant therapy using fondaparinux/edoxaban or fondaparinux/vitamin K antagonist

open access: yesTherapeutics and Clinical Risk Management, 2018
Kazuhiro Shimizu, Takuo Iiduka, Shuji Sato, Hajime Kiyokawa, Takahiro Nakagami, Hiroshi Mikamo, Masayo Kawazoe, Mao Takahashi, Mahito Noro Department of Internal Medicine, Toho University Sakura Medical Center, Sakura City, Chiba, Japan Background: For
Shimizu K   +8 more
doaj   +1 more source

The Fondaparinux Paradox: Fondaparinux-Related Heparin-Induced Thrombocytopenia

open access: yesIndian Journal of Critical Care Medicine, 2018
Fondaparinux, a pentasaccharide administered for heparin-induced thrombocytopenia (HIT), can lead to the occurrence of thrombocytopenia. This patient underwent aortic stent graft placement for Salmonella paratyphi A-infected abdominal aortic aneurysm.
Vadi, Sonali, Peshattiwar, Vishal
openaire   +2 more sources

ANTICOAGULANTS IN ACUTE CORONARY SYNDROME

open access: yesРациональная фармакотерапия в кардиологии, 2016
Clinical efficacy of unfractionated and low molecular heparins in acute coronary syndrome is discussed. New synthetic heparin derivative fondaparinux (Arixtra) is focused. Author’s brief experience of fondaparinux clinical implementation is presented.
I. A. Latfullin, A. A. Podolskaya
doaj   +3 more sources

Custo-efetividade de fondaparinux em pacientes com Síndrome Coronariana Aguda sem supradesnivelamento do ST Cost-effectiveness of fondaparinux in patients with acute coronary syndrome without ST-segment Elevation

open access: yesArquivos Brasileiros de Cardiologia, 2012
FUNDAMENTO: O uso combinado de agentes antitrombínicos, antiplaquetários e estratégias invasivas na síndrome coronariana aguda sem supradesnivelamento do ST (SCAsSST) reduz eventos cardiovasculares. O fondaparinux demonstrou equivalência à enoxaparina na
Camila Pepe   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy